Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse
- PMID: 17136471
- DOI: 10.1245/s10434-006-9241-3
Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse
Abstract
Background: The current recommendation for patients with cutaneous melanoma and a positive sentinel lymph node (SLN) biopsy is a completion lymph node dissection (CLND). This study sought to define a population of SLN-positive patients, based on their histological pattern of SLN metastases, who may not require CLND.
Methods: All patients with SLN-positive cutaneous melanoma who underwent CLND between March 1999 and December 2004 at a single academic institution were enrolled. Metastatic deposits in the SLN were categorized by their histological zone of involvement (subcapsular, parenchymal and/or sinusoidal). Logistic regression was used to examine the effect of SLN zone, size of nodal metastases, and other histological factors on CLND positivity. Kaplan-Meier and Cox models were used to study disease recurrence.
Results: A total of 127 patients were included, and 15.8% had positive non-sentinel nodes. In adjusted analyses, the size of the largest tumor deposit in the SLN was the only factor associated with CLND status. No patients with a tumor deposit <or=0.20 mm had a positive CLND. Although a specific zone of tumor involvement was not predictive of CLND status, involvement of all three zones was independently associated with increased recurrence. Size of the largest tumor deposit was also associated with recurrence, with no recurrences in patients with nodal deposits <or=0.20 mm.
Conclusion: Histologic features of tumor metastases in positive SLN may be useful in defining a population of patients who may be spared CLND and a group at high risk of recurrence.
Comment in
-
Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?Ann Surg Oncol. 2007 Sep;14(9):2437-9. doi: 10.1245/s10434-007-9474-9. Epub 2007 Jun 17. Ann Surg Oncol. 2007. PMID: 17574500 No abstract available.
Similar articles
-
Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.Eur J Surg Oncol. 2008 Jan;34(1):82-8. doi: 10.1016/j.ejso.2007.01.027. Epub 2007 Mar 13. Eur J Surg Oncol. 2008. PMID: 17360144
-
Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.Am Surg. 2007 Jul;73(7):674-8; discussion 678-9. Am Surg. 2007. PMID: 17674939
-
Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.Br J Dermatol. 2007 Jul;157(1):58-67. doi: 10.1111/j.1365-2133.2007.07937.x. Epub 2007 May 14. Br J Dermatol. 2007. PMID: 17501957
-
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.Surg Oncol. 2011 Dec;20(4):259-64. doi: 10.1016/j.suronc.2010.11.001. Epub 2010 Dec 9. Surg Oncol. 2011. PMID: 21145730 Review.
-
Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.Cancer. 2010 Mar 1;116(5):1201-9. doi: 10.1002/cncr.24852. Cancer. 2010. PMID: 20066719 Review.
Cited by
-
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1750-1766. doi: 10.1007/s00259-015-3135-1. Epub 2015 Jul 25. Eur J Nucl Med Mol Imaging. 2015. PMID: 26205952
-
Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound.Radiol Oncol. 2012 Mar;46(1):60-8. doi: 10.2478/v10019-011-0028-1. Epub 2011 Sep 22. Radiol Oncol. 2012. PMID: 22933981 Free PMC article.
-
Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data.Int J Clin Oncol. 2009 Dec;14(6):485-9. doi: 10.1007/s10147-009-0942-z. Epub 2009 Dec 5. Int J Clin Oncol. 2009. PMID: 19967482 Review.
-
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.Cancer. 2009 Nov 1;115(21):5026-37. doi: 10.1002/cncr.24298. Cancer. 2009. PMID: 19658180 Free PMC article.
-
Nonsentinel node metastases in melanoma: do they reflect the biology of the tumor, the lymph node or the surgeon? : Editorial to Accompany Ghaferi et al., ASO-2009-03-0312.R1.Ann Surg Oncol. 2009 Nov;16(11):2965-7. doi: 10.1245/s10434-009-0667-2. Epub 2009 Aug 11. Ann Surg Oncol. 2009. PMID: 19669838 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical